Texas Developmental Center for AIDS Research
德克萨斯艾滋病研究发展中心
基本信息
- 批准号:10609473
- 负责人:
- 金额:$ 115.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-23 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAreaAwardBasic ScienceBiomedical ResearchBiometryBiostatistics CoreCaliforniaCaringCensusesClinicalClinical TrialsCollaborationsCommunicationCommunitiesCommunity OutreachCoupledDataDevelopmentDiagnosisEnvironmentEpidemicEventFosteringFundingFunding OpportunitiesGoalsHIVHIV InfectionsHIV diagnosisHealthHealth InsuranceHealth SciencesHealth ServicesHomeHuman ResourcesInstitutionKnowledgeLeadershipLearningMedicaidMedicineMentorsMissionNewly DiagnosedOccupational activity of managing financesOutcomePersonsPilot ProjectsPoliciesPopulationPreventionProceduresProcessPublic HealthResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch PriorityResearch Project GrantsResource-limited settingResourcesRiskScientistServicesStrategic PlanningTexasTrainingTreatment outcomeUS StateUnited StatesUnited States National Institutes of HealthUniversitiesViralcareercollegecombatcoronavirus pandemicfederal policyhealth determinantsimprovedinnovationmembermultidisciplinarynext generationnonhuman primatenovel coronaviruspreventprogramssubstance usesymposiumsynergismtransmission processvirologyworking group
项目摘要
PROJECT SUMMARY – TEXAS DEVELOPMENTAL CENTER FOR AIDS RESEARCH
In 2019, the US announced a plan to End the HIV Epidemic by 2030. To be successful, strategies that improve
HIV prevention and HIV treatment outcomes are needed. Only 56% of people with HIV (PWH) were virally
suppressed in 2018, a critical determinant of health outcomes and transmission risk, and 51% of HIV
diagnoses in 2018 were in the US South, despite constituting only 38% of the population in the US. Texas is
the second most populous state in the US, behind California, with about 29 million residents, and is in the US
South as defined by CDC and the Census Bureau. Unfortunately, this large Texas population, coupled with
weaker public health and prevention policies and funding across the US South, has a growing HIV population
that lags in critical health outcomes. There is an urgent need for more research and research infrastructure to
combat the HIV epidemic in the US South and specifically in Texas to both contribute to ending the US HIV
epidemic and to learn how to best do that in resource constrained areas of the US. We therefore will establish
a Texas Developmental Center for AIDS Research (D-CFAR) to support the overall mission of the national
CFAR program by facilitating high-priority HIV research and supporting the effort to end the HIV epidemic in
the US. Three institutions have collaborated to propose this D-CFAR: Baylor College of Medicine in Houston,
The University of Texas Health Science Center at Houston and the Texas Biomedical Research Institute in
San Antonio. Based upon the outstanding expertise of its investigators, the Texas D-CFAR will focus its
activities in the five-year funding period on the research theme “Ending HIV and Optimizing HIV Health in
Texas.” To accomplish its goals, the Texas D-CFAR will: 1) Provide organizational and financial management
and facilitate activities and programs that strengthen and enrich the D-CFAR research and intellectual
environment; 2) Support targeted high-priority interdisciplinary pilot research projects, assist in responding to
new HIV-related research initiatives, and facilitate research on ending HIV and improving health of PWH in
Texas; and 3) Provide state-of-the-art expertise, advice, and services to facilitate the range of HIV-related
research for D-CFAR investigators. The Texas D-CFAR will support an Administrative Core, a Developmental
Core, a Basic Science Core and a Clinical and Biostatistics Core to meet investigator needs and catalyze
innovative research. The scientific Cores will build on outstanding strengths in virology, non-human primate
resources, clinical trials research and biostatistics. The D-CFAR will engage a Community Advisory Board and
Internal and External Advisory Boards for guidance. Coupled with outstanding institutional support, the D-
CFAR will stimulate new research and collaborations among basic, translational, clinical, health services and
public health researchers. The D-CFAR will significantly advance knowledge needed to end HIV and improve
the health of PWH in Texas and similar areas, train the next generation of scientists, and grow into a full
CFAR, thereby contributing to ending the HIV epidemic in Texas, the US South, and beyond.
项目概要-德克萨斯州艾滋病研究中心
2019年,美国宣布了一项到2030年结束艾滋病毒流行的计划。要想成功,
需要艾滋病毒预防和艾滋病毒治疗成果。只有56%的艾滋病毒感染者(PWH)是病毒感染者。
在2018年被抑制,这是健康结果和传播风险的关键决定因素,
2018年的诊断发生在美国南部,尽管仅占美国人口的38%。德州是
美国人口第二多的州,仅次于加州,拥有约2900万居民,位于美国
南部由CDC和人口普查局定义。不幸的是,这个庞大的德州人口,加上
在美国南部,公共卫生和预防政策以及资金都比较薄弱,艾滋病毒感染者人数不断增加,
在关键的健康结果方面滞后。迫切需要更多的研究和研究基础设施,
在美国南部,特别是在德克萨斯州,抗击艾滋病毒流行,
流行病,并学习如何在美国资源有限的地区最好地做到这一点。因此,我们将建立
德克萨斯州艾滋病研究发展中心(D-CFAR),以支持国家艾滋病研究中心的总体使命。
CFAR计划,促进高度优先的艾滋病毒研究,并支持在2010年结束艾滋病毒流行的努力。
美方三个机构合作提出了这个D-CFAR:休斯顿的贝勒医学院,
德克萨斯大学休斯顿健康科学中心和德克萨斯生物医学研究所
圣安东尼奥。基于其调查人员的杰出专业知识,德克萨斯州D-CFAR将专注于其
在五年资助期内开展的活动,研究主题是“消除艾滋病毒和优化艾滋病毒健康,
得克萨斯。”为了实现其目标,得克萨斯州D-CFAR将:1)提供组织和财务管理
并促进加强和丰富D-CFAR研究和知识产权的活动和计划
2)支持有针对性的高优先级跨学科试点研究项目,协助应对
推行新的爱滋病研究计划,并促进有关消除爱滋病及改善威尔斯亲王医院健康的研究,
德克萨斯州; 3)提供最先进的专业知识,咨询和服务,以促进艾滋病毒相关的范围
D-CFAR研究人员的研究。德克萨斯州D-CFAR将支持行政核心,发展核心,
核心,基础科学核心和临床和生物统计学核心,以满足研究者的需求,并促进
创新研究。科学核心将建立在病毒学,非人类灵长类动物,
资源、临床试验研究和生物统计学。D-CFAR将聘请社区咨询委员会,
内部和外部咨询委员会提供指导。加上出色的机构支持,D-
CFAR将促进基础、转化、临床、卫生服务和
公共卫生研究人员。D-CFAR将大大推进消除艾滋病毒所需的知识,
在得克萨斯州和类似地区的PWH的健康,培养下一代科学家,并成长为一个完整的
CFAR,从而有助于结束艾滋病毒在得克萨斯州,美国南部和其他地区的流行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas P Giordano其他文献
The New Era of Long-Acting Antiretroviral Therapy: When and Why to Make the Switch
长效抗逆转录病毒治疗的新时代:何时以及为何进行转变
- DOI:
10.1007/s11904-023-00665-x - 发表时间:
2023 - 期刊:
- 影响因子:4.6
- 作者:
Melanie C Goebel;Emmanuel Guajardo;Thomas P Giordano;Shital M Patel - 通讯作者:
Shital M Patel
Thomas P Giordano的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas P Giordano', 18)}}的其他基金
Wastewater Sampling: A New Tool to Accelerate Ending the HIV Epidemic
废水采样:加速结束艾滋病毒流行的新工具
- 批准号:
10762555 - 财政年份:2023
- 资助金额:
$ 115.65万 - 项目类别:
VA Video Connect to Improve Access to Multi-disciplinary Specialty Care
VA 视频连接可改善获得多学科专业护理的机会
- 批准号:
10329924 - 财政年份:2020
- 资助金额:
$ 115.65万 - 项目类别:
VA Video Connect to Improve Access to Multi-disciplinary Specialty Care
VA 视频连接可改善获得多学科专业护理的机会
- 批准号:
9721402 - 财政年份:2020
- 资助金额:
$ 115.65万 - 项目类别:
VA Video Connect to Improve Access to Multi-disciplinary Specialty Care
VA 视频连接可改善获得多学科专业护理的机会
- 批准号:
10561628 - 财政年份:2020
- 资助金额:
$ 115.65万 - 项目类别:
Developing an Intervention to Retain HIV-infected Veterans in HIV Care
制定干预措施,让感染艾滋病毒的退伍军人继续接受艾滋病毒护理
- 批准号:
8182121 - 财政年份:2010
- 资助金额:
$ 115.65万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 115.65万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 115.65万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 115.65万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 115.65万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 115.65万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 115.65万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 115.65万 - 项目类别: